International Consolidated Airlines Group S.A. (0A2L)
London Stock Exchange · UK · prices in USD · close of 23 Oct 2026
Key indicators
| Last close | USD 10.60 |
|---|---|
| 52-week range | 9.58 – 12.19 |
| Return, 1 month / 3 months | −7.2% / −7.2% |
| Return, 1 year / 3 years | +1.6% / +226.2% |
| Trend | Below its 200-day average |
| RSI (14) | 0 |
| Volatility (1 year) | 36.5% |
| Worst drawdown (1 year) | -21.4% |
| Average daily value traded | 0.00M USD |
| Dividend yield | 2.8% |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
International Consolidated Airlines Group is an airline group based in Spain that owns and operates several carriers, including British Airways, Iberia, Vueling and Aer Lingus. Through these airlines it carries passengers on short-haul and long-haul routes across Europe and to other continents, and it also provides air cargo services and runs frequent-flyer loyalty programmes. Its customers are leisure and business travellers, along with freight shippers, and its airlines are based at hubs in the United Kingdom, Spain and Ireland.
On this site International Consolidated Airlines Group S.A. appears as a stock on the London Stock Exchange (UK), code 0A2L, with prices in US dollars (USD). Our dividend records, which start in 2019, show payments in 4 different calendar years. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
International Consolidated Airlines Group S.A. (0A2L) trades on the London Stock Exchange in UK. It last closed at USD 10.60 on 23 October 2026.
Its price-based Market X-Ray is 45 out of 100 (a weak price profile), ranking 2,367 of 3,789 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price rose 1.6% and over the last three months it fell 7.2%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on London Stock Exchange
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 56 · Fair | Mixed trend against its averages. | |
| Above 200-day average | -2.3% | ||
| From 52-week high | -13.0% | ||
| Momentum | 53 · Fair | Typical recent returns for this exchange. | |
| 3-month return | -7.2% | ||
| 6-month return | 10.7% | ||
| 12-month return, skipping the last month | 9.4% | ||
| Stability (higher is calmer) | 58 · Fair | Typical risk for this exchange. | |
| Volatility, 1 year (lower is calmer) | 36.5% | ||
| Worst drawdown, 1 year (smaller is calmer) | -21.4% | ||
| Liquidity | 3 · Weak | Thinly traded: prices can jump and exits can be hard. | |
| Average daily value traded | 0.00M USD | ||
| Zero-volume days | 95.0% | ||
| Income | 28 · Weak | Dividend is small or irregular. | |
| Dividend yield | 2.8% | ||
| Years with dividends | 3 |
Strengths
No lens stands out as a clear strength against its exchange.
Weak spots
- Liquidity: Thinly traded: prices can jump and exits can be hard.
- Income: Dividend is small or irregular.
Returns
| 1 week | −7.2% |
|---|---|
| 1 month | −7.2% |
| 3 months | −7.2% |
| 6 months | +10.7% |
| 1 year | +1.6% |
| 3 years | +226.2% |
| 5 years | +141.8% |
Signals
| 50-day / 200-day average | 11.40 / 10.85 |
|---|---|
| Golden / death cross (60 days) | None |
| New 52-week high | No |
| Bullish RSI divergence | No |
| Average daily range (ATR) | 0.06 |
Technical summary
Recent dividends
| Ex-dividend date | Amount per share |
|---|---|
| 26 Jun 2026 | GBP 0.1143 |
| 1 Dec 2025 | GBP 0.1115 |
| 27 Jun 2025 | GBP 0.1413 |
| 6 Sep 2024 | GBP 0.0663 |
| 8 Oct 2020 | GBP 0.6569 |
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on London Stock Exchange; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.